Rentokil Initial Plc /Fi (RKLIF) EBITDA (2021 - 2025)

Rentokil Initial (RKLIF) has reported EBITDA for 5 consecutive years, with $511.0 million the latest figure, recorded in Q4 2025.

• In Q4 2025, EBITDA fell 66.17% year-over-year to $511.0 million; the TTM figure through Dec 2025 stood at $3.3 billion (down 33.06% YoY), while the FY2025 annual figure was $1.1 billion, down 29.17% from the prior year.
• EBITDA rose to $511.0 million in Q4 2025 per RKLIF's latest filing, from -$230.0 million in the prior quarter.
• Across five years, EBITDA topped out at $1.5 billion in Q4 2023 and bottomed at -$230.0 million in Q3 2025.
• Historically, EBITDA has averaged $872.4 million across 5 years, with a median of $959.4 million in 2022.
• Annual changes were most pronounced in 2023 — EBITDA surged 51.27% — and 2025, when it tumbled 66.17%.
• Rentokil Initial's EBITDA stood at $911.3 million in 2021, then increased by 10.57% to $1.0 billion in 2022, then soared by 51.27% to $1.5 billion in 2023, then fell by 0.88% to $1.5 billion in 2024, then sank by 66.17% to $511.0 million in 2025.
• Business Quant data shows RKLIF's EBITDA at $511.0 million in Q4 2025, -$230.0 million in Q3 2025, and $1.5 billion in Q4 2024.